protein tyrosine phosphatase-1B inhibitors (GSK/Cold Spring Harbor)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameprotein tyrosine phosphatase-1B inhibitors (GSK/Cold Spring Harbor)
Drug Alias NamePTP-1B inhibitors (GSK/Cold Spring Harbor)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine phosphatase 1B inhibitors
TargetsProtein-tyrosine phosphatase 1B
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A